Johnson & Johnson must pay more than $42 million to a Massachusetts man who alleges that he developed mesothelioma, a rare ...

Johnson & Johnson is still facing many lawsuits that threaten its business. It may face additional challenges from patent cliffs and regulatory changes. Despite that, the drugmaker has important ...

New Brunswick, New Jersey-based Johnson & Johnson (JNJ) primarily focuses on drug discovery and manufacturing but has a ...

The big appeal of Johnson & Johnson over the years has been that it's a relatively safe stock to own, and it also offers an attractive dividend yield of 2.8% -- the S&P 500 average is just over 1.5%.

Johnson & Johnson’s revenue growth of 16% to $95 billion over the last twelve months, compared to $82 billion in 2019, 2. a 1.5% fall in its total shares outstanding to 2.6 billion, partly ...

Johnson & Johnson (JNJ 0.44%) is an iconic global healthcare company. It was originally formed in 1866 when three brothers (Robert, Edward, and James Johnson) founded the company to focus on ...

Johnson & Johnson shares climbed Friday after the conglomerate behind Band-Aid, Neutrogena and a coronavirus vaccine announced plans to split into two companies. (Richard Drew/AP) ...